New drug development faces high costs, long delays and high failure rates. RePo-SUDOE emerges as a response to these challenges, focusing on drug repurposing: a strategy that repurposes existing drugs for new therapeutic applications, benefiting the pharmaceutical industry, society and patients.
Our main objective is to turn the SUDOE area into a European benchmark in drug repurposing, developing and disseminating advanced technologies that increase competitiveness and attract skilled talent.
How do we achieve this?
- We promote scientific knowledge and disseminate drug repurposing technologies among public and private actors, raising our R&D centres to the level of European excellence.
- We foster multidisciplinary collaboration through a transnational network, identifying innovative opportunities and developing methodologies, in the first instance, to treat cancer.
- We created a 3D visualisation room with virtual and augmented reality technologies, offering an interactive and educational experience for young students and researchers.
RePo-SUDOE unites for the first time partners from different SUDOE regions and areas of the drug development value chain in a common drug repurposing project. It will provide society with easily accessible scientific information and advanced visualisation technologies, strengthening the area of drug repurposing in the SUDOE space.
